Company intelligence / Profile preview
Sewon Cellontech Co., Ltd.
Seoul, Seoul, South Korearmsbio.net ↗
- Ownership
- Private
- Employees
- ~48
- Development stage
- Other
01
Overview
The company has developed and commercialized multiple cell therapy products and medical devices, including ChondronTM for cartilage repair and RMS OssronTM for bone formation. Their products have received regulatory approvals in Korea and internationally.
- Therapeutic areas
- DermatologyRheumatology
- Modalities
- Cell therapyCollagen-based productsTissue engineering
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
LinkoCare Life Sciences (Sweden)
Beyond the preview
Go deeper on Sewon Cellontech Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sewon Cellontech Co., Ltd..